Description
Composition- Telmisartan 40 mg + Rosuvastatin 10 mg
Mode of Action- Combines blood pressure control through angiotensin receptor blockade with lipid lowering through HMG-CoA reductase inhibition for cardiovascular risk reduction.
USPs- Dual BP and lipid management; useful in cardiometabolic patients; supports overall cardiovascular protection.
Prescribing Specialties- Cardiologist, General Physician
